A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B
Clinical trial NCT03861273 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03861273
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2022-11-16
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.